Free Trial

Aurora Cannabis (ACB) Competitors

Aurora Cannabis logo
C$8.25 0.00 (0.00%)
As of 10:37 AM Eastern

ACB vs. BHC, THCX, CRON, GUD, TLRY, WEED, FIRE, EPI, OGI, and CPH

Should you be buying Aurora Cannabis stock or one of its competitors? The main competitors of Aurora Cannabis include Bausch Health Companies (BHC), Hydropothecary (THCX), Cronos Group (CRON), Knight Therapeutics (GUD), Tilray Brands (TLRY), Canopy Growth (WEED), Supreme Cannabis (FIRE), ESSA Pharma (EPI), Organigram (OGI), and Cipher Pharmaceuticals (CPH). These companies are all part of the "drug manufacturers - specialty & generic" industry.

Aurora Cannabis vs. Its Competitors

Bausch Health Companies (TSE:BHC) and Aurora Cannabis (TSE:ACB) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, profitability, media sentiment, institutional ownership, risk, dividends, valuation, earnings and community ranking.

Bausch Health Companies has a beta of 0.77, suggesting that its share price is 23% less volatile than the S&P 500. Comparatively, Aurora Cannabis has a beta of 2.71, suggesting that its share price is 171% more volatile than the S&P 500.

In the previous week, Bausch Health Companies' average media sentiment score of 0.00 equaled Aurora Cannabis'average media sentiment score.

Company Overall Sentiment
Bausch Health Companies Neutral
Aurora Cannabis Neutral

Aurora Cannabis has a consensus target price of C$8.75, suggesting a potential upside of 6.06%. Given Aurora Cannabis' stronger consensus rating and higher probable upside, analysts plainly believe Aurora Cannabis is more favorable than Bausch Health Companies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bausch Health Companies
0 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Aurora Cannabis
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
2 Strong Buy rating(s)
3.33

79.0% of Bausch Health Companies shares are owned by institutional investors. Comparatively, 13.4% of Aurora Cannabis shares are owned by institutional investors. 11.3% of Bausch Health Companies shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Aurora Cannabis received 492 more outperform votes than Bausch Health Companies when rated by MarketBeat users. However, 63.93% of users gave Bausch Health Companies an outperform vote while only 63.14% of users gave Aurora Cannabis an outperform vote.

CompanyUnderperformOutperform
Bausch Health CompaniesOutperform Votes
39
63.93%
Underperform Votes
22
36.07%
Aurora CannabisOutperform Votes
531
63.14%
Underperform Votes
310
36.86%

Bausch Health Companies has a net margin of -1.88% compared to Aurora Cannabis' net margin of -22.55%. Bausch Health Companies' return on equity of 15.87% beat Aurora Cannabis' return on equity.

Company Net Margins Return on Equity Return on Assets
Bausch Health Companies-1.88% 15.87% 4.16%
Aurora Cannabis -22.55%-8.36%-1.87%

Aurora Cannabis has lower revenue, but higher earnings than Bausch Health Companies. Bausch Health Companies is trading at a lower price-to-earnings ratio than Aurora Cannabis, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bausch Health CompaniesC$6.69B0.29-C$125.65M-C$0.68-10.83
Aurora CannabisC$195.83M2.30-C$44.16M-C$0.81-10.19

Summary

Bausch Health Companies and Aurora Cannabis tied by winning 8 of the 16 factors compared between the two stocks.

Get Aurora Cannabis News Delivered to You Automatically

Sign up to receive the latest news and ratings for ACB and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ACB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ACB vs. The Competition

MetricAurora CannabisDrug Manufacturers IndustryMedical SectorTSE Exchange
Market CapC$451.34MC$2.15BC$5.60BC$6.07B
Dividend YieldN/A2.92%5.28%6.72%
P/E Ratio-10.194.0127.2338.28
Price / Sales2.30618.95417.65966.99
Price / Cash1.2510.2538.2583.29
Price / Book0.756.977.124.27
Net Income-C$44.16MC$20.70BC$3.23BC$301.20M
7 Day Performance11.64%-0.67%2.74%1.84%
1 Month Performance16.86%4.34%8.94%6.33%
1 Year Performance-0.36%105.02%31.59%23.18%

Aurora Cannabis Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ACB
Aurora Cannabis
0.2749 of 5 stars
C$8.25
flat
C$8.75
+6.1%
+1.9%C$451.34MC$195.83M-10.191,073
BHC
Bausch Health Companies
N/AC$6.66
+2.0%
N/A-13.3%C$1.73BC$6.69B-9.7519,900
THCX
Hydropothecary
N/AC$5.30
+6.6%
N/A+0.0%C$949.11MN/A0.00N/AHigh Trading Volume
CRON
Cronos Group
N/AC$2.67
-1.8%
N/A-20.8%C$705.05MC$76.86M-14.86450News Coverage
GUD
Knight Therapeutics
1.6896 of 5 stars
C$6.02
+0.3%
C$7.15
+18.8%
+4.5%C$608.92MC$348.70M-20.10725
TLRY
Tilray Brands
N/AC$0.55
flat
N/A-75.9%C$354.40MC$610.34M-1.332,650News Coverage
WEED
Canopy Growth
0.3214 of 5 stars
C$2.20
-4.8%
C$4.31
+95.8%
-78.6%C$353.91MC$519.68M-0.322,700Gap Up
FIRE
Supreme Cannabis
N/AN/AN/AN/AC$259.40MC$53.29M-10.97400
EPI
ESSA Pharma
N/AC$8.20
+7.2%
N/A+0.0%C$237.87MN/A-8.2725
OGI
Organigram
2.3205 of 5 stars
C$1.90
+2.2%
C$3.33
+75.0%
-8.7%C$234.73MC$180.58M-4.02987News Coverage
Gap Up
CPH
Cipher Pharmaceuticals
1.3982 of 5 stars
C$12.77
-3.6%
C$14.75
+15.5%
+46.9%C$229.26MC$19.03M14.105

Related Companies and Tools


This page (TSE:ACB) was last updated on 6/12/2025 by MarketBeat.com Staff
From Our Partners